Leanne Kelly - Feb 15, 2022 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Chief Financial Officer
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
Feb 15, 2022
Transactions value $
$281,500
Form type
4
Date filed
3/1/2022, 04:03 PM
Previous filing
Jun 4, 2021
Next filing
Sep 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $282K +50K $5.63 50K Feb 15, 2022 Common Stock 50K $5.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported late due to administrative error.
F2 Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.